ResMed to use credit facility borrowings to acquire MatrixCare

By Marisa Wong

Morgantown, W.Va., Nov. 5 – ResMed plans to use its credit facility to fund its acquisition of MatrixCare, according to a press release.

The transaction is valued at $750 million and is expected to close by the end of the second quarter of ResMed’s fiscal year 2019.

ResMed is a San Diego-based medical device company focused on the diagnosis, treatment and management of sleep-disordered breathing, COPD and other chronic conditions. MatrixCare is a long-term post-acute care software company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.